drugset / Trial / NCT01210950

Distraction Osteogenesis in Limb-length Discrepancy With Mesenchymal Cell Transplantation

NCT01210950 ↗

Phase 1 Completed 6 enrolled Royan Institute
NaSingle-groupOpen-labelTreatment

Summary

Limb-length discrepancy can be due to many causes. These are divided into three groups: congenital (from birth), developmental (from a childhood disease or injury that slows or damages the growth plates), and posttraumatic (from a fracture that leads to shortening of the bone ends). There are three ways to equalize the limb-length discrepancy: use a shoe lift, shorten the long leg, lengthen the short leg. Most patients do not like wearing a lift greater than 2 cm (3/4 in). For discrepancies greater than 2 cm but less than 5 cm (2 in), shortening of the long leg can be considered, especially for tall persons. For growing children, this can be easily accomplished with a small, minimally invasive, uncomplicated procedure called epiphysiodesis.The investigators aim to evaluate if injection of bone marrow derived mesenchymal stem cells can shorten the treatment period by acceleration of bone regeneration during distraction osteogenesis.

Timeline

Start
2009-09
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal cells Cell therapy — —
Background Plasma reach Protein Unknown — —

Indications

No indication recorded.